Literature DB >> 19030915

Plasma exchange for removal of antibeta1-adrenergic receptor antibody in a small child with dilated cardiomyopathy.

Hisashi Sugiyama1, Minako Hoshiai, Kanji Sugita, Ken-ichi Matsuda.   

Abstract

A 5-year-old boy was diagnosed with dilated cardiomyopathy (DCM) at 8 months of age. He underwent plasma exchange (PE) three times during 4 days because his antibeta1-adrenergic receptor antibody titer was 160 times the background density on enzyme-linked immunosorbent assay. BNP titer decreased from 1320 pg/ml before to 506 pg/ml after PE. Dobutamine infusion was discontinued after PE because of improving cardiac function. After PE, his antibeta1-adrenergic receptor antibody titer was < 20 times the background density. When patients have a high titer of antibeta1-adrenergic receptor antibody, PE should be considered, even in small children, as an alternative treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030915     DOI: 10.1007/s00246-008-9332-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  12 in total

1.  Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up.

Authors:  Wolf V Dörffel; Gerd Wallukat; Yvonnne Dörffel; Stephan B Felix; Gert Baumann
Journal:  Int J Cardiol       Date:  2004-12       Impact factor: 4.164

2.  Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy.

Authors:  M O Gesinde; L B Tan; H C Gooi
Journal:  J Clin Apher       Date:  2007       Impact factor: 2.821

3.  Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.

Authors:  Alexander Staudt; Marko Böhm; Fabian Knebel; Yvonne Grosse; Claudia Bischoff; Astrid Hummel; Johannes B Dahm; Adrian Borges; Nicoline Jochmann; Klaus D Wernecke; Gerd Wallukat; Gert Baumann; Stephan B Felix
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

4.  Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.

Authors:  Stephan B Felix; Alexander Staudt; Martin Landsberger; Yvonne Grosse; Verena Stangl; Thomas Spielhagen; Gerd Wallukat; Klaus D Wernecke; Gert Baumann; Karl Stangl
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

5.  Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.

Authors:  S B Felix; A Staudt; W V Dörffel; V Stangl; K Merkel; M Pohl; W D Döcke; S Morgera; H H Neumayer; K D Wernecke; G Wallukat; K Stangl; G Baumann
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

6.  Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.

Authors:  Fabian Knebel; Marco Böhm; Alexander Staudt; Adrian C Borges; Mirko Tepper; Nicoline Jochmann; Klaus D Wernicke; Stephan Felix; Gert Baumann
Journal:  Int J Cardiol       Date:  2004-12       Impact factor: 4.164

7.  Autoantigen estimation and simple screening assay against cardiodepressant autoantibodies in patients with dilated cardiomyopathy.

Authors:  Akiyasu Baba
Journal:  Ther Apher Dial       Date:  2008-04       Impact factor: 1.762

8.  Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.

Authors:  Alexander Staudt; Yvonne Staudt; Marcus Dörr; Marco Böhm; Fabian Knebel; Astrid Hummel; Lydia Wunderle; Malte Tiburcy; Klaus D Wernecke; Gert Baumann; Stephan B Felix
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

9.  Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.

Authors:  Alexander Staudt; Yvonne Staudt; Astrid Hummel; Klaus Empen; Marcus Dörr; Christiane Trimpert; Katrin Birkenmeier; Uwe Kühl; Michel Noutsias; Dirk Russ; Stephan B Felix
Journal:  Ther Apher Dial       Date:  2006-02       Impact factor: 1.762

10.  Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy.

Authors:  Reza Mobini; Alexander Staudt; Stephan B Felix; Gert Baumann; Gert Wallukat; Johanna Deinum; Helen Svensson; Ake Hjalmarson; Michael Fu
Journal:  J Autoimmun       Date:  2003-06       Impact factor: 7.094

View more
  2 in total

1.  Outcomes of plasma exchange for severe dilated cardiomyopathy in children.

Authors:  Keiichi Koizumi; Minako Hoshiai; Takako Toda; Nobuyuki Katsumata; Hiroaki Kise; Yohei Hasebe; Yousuke Kouno; Shigeaki Kaga; Shoji Suzuki; Kanji Sugita
Journal:  Heart Vessels       Date:  2016-04-27       Impact factor: 2.037

2.  Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities.

Authors:  Takeshi Moriguchi; Keiichi Koizumi; Kenichi Matsuda; Norikazu Harii; Junko Goto; Daiki Harada; Hisanori Sugawara; Minako Hoshiai; Hiroaki Kise; Akiyasu Baba
Journal:  J Artif Organs       Date:  2017-04-05       Impact factor: 1.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.